Showing results (11-20 of 283) with videos related to

Sort By:
Pageof 29
The American Journal of Cardiology|January 25, 1985
Therapeutic application of calcium-channel antagonists for pulmonary hypertensionM Packer
Journal of Cardiovascular Pharmacology|January 1, 1989
Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonistsM Packer
Chest|October 1, 1985
Does pulmonary vasoconstriction play an important role in patients with primary pulmonary hypertension? A skeptic's view of vasodilator therapyM Packer
Circulation|August 1, 1990
Pathophysiological mechanisms underlying the effects of beta-adrenergic agonists and antagonists on functional capacity and survival in chronic heart failureM Packer
Journal of the American College of Cardiology|July 1, 1992
The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failureM Packer
The American Journal of Medicine|June 22, 1984
Conceptual dilemmas in the classification of vasodilator drugs for severe chronic heart failure. Advocacy of a pragmatic approach to the selection of a therapeutic agentM Packer
Progress in Cardiovascular Diseases|August 26, 1998
Beta-adrenergic blockade in chronic heart failure: principles, progress, and practiceM Packer
The American Journal of Cardiology|June 4, 1992
Long-term strategies in the management of heart failure: looking beyond ventricular function and symptomsM Packer
Drugs|January 1, 1986
The role of vasodilator therapy in the treatment of severe chronic heart failureM Packer
Cardiovascular Drugs and Therapy|January 1, 1989
Does digitalis work in chronic heart failure? The end of a 200-year-old controversyM Packer
Pageof 29